The Lancet Respiratory Medicine 2019

5 papers
In 2019, *The Lancet Respiratory Medicine* featured research spanning fibrotic diseases, critical care, oncology, and infectious respiratory conditions. A prominent theme involved the identification of cellular biomarkers, specifically the use of monocyte counts to predict outcomes in patients with fibrotic lung diseases. Clinical trial results also addressed acute care procedures, such as the PrePARE study, which evaluated the impact of fluid boluses on cardiovascular stability during tracheal intubation in critically ill adults. Other research focused on refining diagnostic and therapeutic approaches for diverse patient populations. This included recommendations for standardizing pediatric pneumonia diagnosis in field trials and a phase 2 trial assessing the efficacy of ensartinib for ALK-positive non-small-cell lung cancer. Additionally, the FLU-IVIG trial investigated the use of hyperimmune intravenous immunoglobulin for treating influenza A and B. Collectively, these works highlight a focus on improving prognostic accuracy and evaluating targeted interventions for both chronic pulmonary conditions and acute viral infections.

Top Research Directions

The 2 research directions with The Lancet Respiratory Medicine 2019 papers, ranked by paper count. Share is the fraction of the edition’s papers in the direction.

#DirectionPapersShare
1Mapping Immune Landscapes with Multi-Parameter Flow Cytometry120.0%
2Why Billing Codes Fail as Clinical Ground Truth120.0%

Download all directions as CSV

Institutions

Institutions credited by The Lancet Respiratory Medicine 2019 papers: a paper credits every institution named in its affiliations, once. 8 institutions share 1 credited papers.

#InstitutionPapersShare
1Cornell University 1100.0%
2Northwestern University 1100.0%
3Stanford University 1100.0%
4University of Michigan 1100.0%
5Vanderbilt University 1100.0%
6Vanderbilt University Medical Center 1100.0%
7Weill Cornell Medicine 1100.0%
8Yale University 1100.0%

Download all institutions as CSV

About this data

Papers. The Lancet Respiratory Medicine 2019 lists 5 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers.

Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 1 of 5 papers (20.0%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.

Data. Counts come from Lacuna’s data build of 2026-11-18 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “The Lancet Respiratory Medicine 2019”, https://lacuna.tiptreesystems.com/venue/the-lancet-respiratory-medicine/2019.

Top Authors

AuthorPapers
Aris T Papageorghiou1
Jianhua Chen1

Papers

Title
Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial
Challenges in the diagnosis of paediatric pneumonia in intervention field trials: recommendations from a pneumonia field trial working group
Effect of a fluid bolus on cardiovascular collapse among critically ill adults undergoing tracheal intubation (PrePARE): a randomised controlled trial
Efficacy, safety, and biomarker analysis of ensartinib in crizotinib-resistant, ALK-positive non-small-cell lung cancer: a multicentre, phase 2 trial
Increased monocyte count as a cellular biomarker for poor outcomes in fibrotic diseases: a retrospective, multicentre cohort study